Navigation Links
NeoClinical Launches Neo PayPerPatient Clinical Trial Recruitment
Date:2/20/2013

Palo Alto, CA/ Sydney, Australia (PRWEB) February 20, 2013

NeoClinical™, the leading digital clinical trial recruitment agency for Australia, New Zealand and Asian markets today officially launched its latest recruitment product, Neo PayPerPatient. Neo PayPerPatient has emerged from 6 months of beta testing, including regulatory compliance, and integration of some of the latest online consumer engagement software and tools.Neo PayPerPatient has already built powerful databases of people wanting more information about the latest clinical trials for conditions including gout, arthritis, Alzheimer’s, menopause, diabetes, prostate cancer and asthma.

Get the PayPerPatient Data Sheet here.

Neo PayPerPatient is a risk share pay-as-you-go solution for new studies or current studies that are under-performing and need a boost to recruitment.Sponsors only pay a nominal fee for partially screened patients then a moderate fee for those that proceed to full enrolment. NeoClinical™ manages all the rest.

NeoClinical™‘s advertising and PR expertise as well as the team’s considerable online and social media experience is already delivering results for clients – saving money and most importantly time. NeoClinical™ study recruitment campaigns feature innovative and EC compliant advertising, public relations and online content marketing campaigns. With more than 80% of internet users seeking health information online and a third of US adults online to look at health information, getting in front of people online is key.

“Dr. Google is where it is all happening, but you need to give people quality informative content that answers their online search,” said co-founder Susan Fitzpatrick-Napier. “NeoClinical™ is a trusted source for original and authentic health news that informs and updates our potential patients.”

NeoClinical™ typically achieves referral conversion rates of 40-60% and recently achieved a 63% conversion rate for a New Zealand Study.

“For too long companies have been spending valuable time and money searching for people. Don’t waste money finding people you don’t need. Just make it easy for people you need to find you,” said Fitzpatrick-Napier.

For more information about the latest research and new clinical trials please visit http://www.NeoClinical.com.

About NeoClinical™ http://www.neoclinical.com
NeoClinical™ is the region's foremost clinical trial marketing agency dedicated to sharing news on the latest clinical research in Australia, New Zealand, and Asia including Korea, Taiwan, Malaysia, India and China.
NeoClinical™ uses the latest population health data and media consumption data to communicate via a sophisticated mix of public relations, advertising and online content marketing. This is combined with the highest level of reporting, measurement and analytics.
NeoClinical™ is headed by award-winning communications executives who have managed global campaigns for some of the world’s leading consumer and healthcare companies.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10440216.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. BioLife Solutions Launches Search Engine Optimized Website and 1,000 Free Samples Offer
4. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
5. Neogen Launches Fully Quantitative Lateral Flow Test for DON
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. iHealth Lab Launches Personalized Web Portal to Store Your Vitals
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Upsher-Smith Launches B-Nexa® Prescription Prenatal Vitamin With B Vitamins and Ginger for Nausea and Vomiting of Pregnancy
10. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
11. ERT Launches New Website to Support Significant Commercial Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):